HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Counterpoint Mutual Funds LLC

Counterpoint Mutual Funds LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 78.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 4,582 shares of the company’s stock after acquiring an additional 2,021 shares during the period. Counterpoint Mutual Funds LLC’s holdings in HCA Healthcare were worth $1,375,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. First Eagle Investment Management LLC boosted its stake in shares of HCA Healthcare by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after purchasing an additional 23,177 shares during the period. FMR LLC increased its stake in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after acquiring an additional 2,397,883 shares during the period. Franklin Resources Inc. lifted its stake in HCA Healthcare by 11.7% during the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after purchasing an additional 174,946 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in HCA Healthcare by 2.8% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after buying an additional 41,190 shares during the period. Finally, Janus Henderson Group PLC raised its holdings in shares of HCA Healthcare by 12.0% during the third quarter. Janus Henderson Group PLC now owns 1,339,638 shares of the company’s stock worth $544,467,000 after acquiring an additional 143,995 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $319.82 on Monday. The company has a 50-day simple moving average of $319.00 and a two-hundred day simple moving average of $344.95. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company has a market capitalization of $78.74 billion, a PE ratio of 14.56, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the company posted $5.90 EPS. Research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be issued a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s payout ratio is 13.11%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on HCA. Morgan Stanley decreased their price target on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research note on Tuesday, December 17th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada cut their price objective on HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Finally, Bank of America reduced their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.